Back

Predicting the final diagnosis in patients with suspected amyloid cardiomyopathy referred for tissue biopsy

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Cardiac injury and heart failure: integrating biomarkers and imaging Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Alberto Aimo

Sant'Anna School of Advanced Studies, Pisa (Italy)

7 More presentations in this session

Presentation thumbnail
Longitudinal proteomic changes following hospitalization for acute heart failure
Mrs A. Dieden (Malmoe, SE)
Abstract Slides Video
Presentation thumbnail
Detecting transthyretin protein misfolding before amyloid deposition: a structural proteomics blood test for early identification of transthyretin amyloid (ATTR) cardiomyopathy
Doctor S. Pankow (La Jolla, US)
Abstract Slides Video
Presentation thumbnail
Immediate reduction in stressed blood volume after percutaneous ventricular assist device implantation in cardiogenic shock: Reverse translational study suggesting baroreflex-mediated redistribution
Doctor M. Otake (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Natriuretic peptides in acute decompensated heart failure: insights from the DAPA ACT HF-TIMI 68 Trial
Doctor E. O'Meara (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Impact of IFCC healthy reference population criteria on TnT hs Gen 6 99th percentile URLs: REF-TSIX
Professor L. Daniels (La Jolla, US)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac injury and heart failure: integrating biomarkers and imaging

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Simple and specific prediction of the final diagnosis in patients with suspected amyloid cardiomyopathy and indication to tissue biopsy
17 May 2025
thumbnail
Congress Presentation
Beyond conduction disease: a prospective screening study of transthyretin cardiac amyloidosis in older patients referred for device therapy after syncope
29 August 2026
thumbnail
Congress Presentation
Multimodal assessment of disease progression risk among transthyretin amyloid cardiomyopathy patients under disease-modifying therapy
30 August 2026
thumbnail
Congress Presentation
Screening performance of a deep learning model versus an automated wall thickness score in biopsy-proven cardiac amyloidosis
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources